SIM
BIOR

Seaview Investment Managers’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Seaview Investment Managers’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80
Closed -$23K – 112
2022
Q1 		$23K Buy
+80
New +$30.4K 0.01% 105

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Seaview Investment Managers's BIOR Position: Q2 2022 in Review

Seaview Investment Managers sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2022, closing a stake of 80 shares — an estimated $23K sold.

Seaview Investment Managers first reported a position in BIOR in Q1 2022 and held it in 1 quarter. The position peaked at $23K in Q1 2022. 46 funds tracked by Wall St. Rank hold BIOR as of Q2 2022.

  • Seaview Investment Managers reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Seaview Investment Managers sold 80 Biora Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $23K.
  • Seaview Investment Managers first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Seaview Investment Managers's Biora Therapeutics, Inc. Common Stock position peaked at $23K in Q1 2022.
  • 46 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Seaview Investment Managers's 13F filing for Q2 2022, filed 20 Jul 2022.